Is meloxicam (nonsteroidal anti-inflammatory drug (NSAID)) effective for managing menstrual pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Meloxicam for Managing Menstrual Pain

Meloxicam is effective for managing menstrual pain (dysmenorrhea) and may have better gastrointestinal tolerability compared to some other NSAIDs, making it a reasonable first-line treatment option for menstrual pain. 1

Mechanism and Efficacy

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes responsible for prostaglandin production. Prostaglandins are key mediators in the pathophysiology of menstrual pain, causing uterine contractions and pain.

Research evidence supports the use of NSAIDs for dysmenorrhea:

  • A double-blind study comparing meloxicam (7.5 mg and 15 mg once daily) with mefenamic acid (500 mg three times daily) found that both meloxicam doses were comparable to mefenamic acid in relieving dysmenorrhea symptoms 1
  • Meloxicam demonstrated better gastrointestinal tolerability compared to mefenamic acid, with fewer GI adverse events 1
  • A Cochrane review confirmed that NSAIDs are significantly more effective than placebo for pain relief in primary dysmenorrhea (OR 4.37,95% CI 3.76 to 5.09) 2

Dosing and Administration

For menstrual pain, the recommended dosing is:

  • Meloxicam 7.5-15 mg once daily
  • Take with food to minimize gastrointestinal side effects
  • Begin treatment at the onset of menstrual symptoms and continue for 3-5 days as needed

Advantages of Meloxicam

  • Once-daily dosing (compared to multiple daily doses required for other NSAIDs like mefenamic acid)
  • Better gastrointestinal tolerability profile than some other NSAIDs 1
  • Effective pain relief comparable to other NSAIDs commonly used for dysmenorrhea

Safety Considerations and Precautions

As with all NSAIDs, meloxicam carries certain risks:

  1. Gastrointestinal effects: Risk of ulcers and bleeding in the stomach and intestines, which can occur without warning symptoms 3

    • Risk increases with:
      • Longer duration of use
      • Concomitant use of corticosteroids or anticoagulants
      • Smoking, alcohol consumption
      • Older age
      • Poor health
  2. Cardiovascular risks: NSAIDs may increase risk of heart attack and stroke

  3. Other potential side effects:

    • Fluid retention
    • Headaches
    • Dizziness
    • Drowsiness

Alternative Treatment Options

If meloxicam is not effective or not tolerated, consider:

  1. Other NSAIDs: Naproxen (500 mg twice daily), ibuprofen (600-800 mg every 6-8 hours) 4

  2. Hormonal contraceptives: For women who also desire contraception, hormonal methods can be effective for managing dysmenorrhea 5

    • Combined hormonal contraceptives (pills, patches, rings)
    • Levonorgestrel-releasing intrauterine system (LNG-IUD)
  3. Non-pharmacological approaches:

    • Heat therapy
    • Exercise
    • Transcutaneous electrical nerve stimulation (TENS)

Special Considerations

  • Contraindications: Avoid in patients with history of asthma attacks, hives, or allergic reactions to aspirin or other NSAIDs
  • Pregnancy: NSAIDs should not be used by pregnant women late in their pregnancy 3
  • Breastfeeding: Discuss with healthcare provider before use

Monitoring and Follow-up

  • Evaluate response to treatment after 1-2 menstrual cycles
  • If inadequate relief, consider increasing dose (up to 15 mg daily) or switching to alternative treatment
  • Monitor for side effects, particularly gastrointestinal symptoms

In conclusion, meloxicam represents an effective option for managing menstrual pain with the advantage of once-daily dosing and potentially better gastrointestinal tolerability compared to some other NSAIDs. However, as with all NSAIDs, it should be used at the lowest effective dose for the shortest duration needed to control symptoms.

References

Research

Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.

The Cochrane database of systematic reviews, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaginal Bleeding in HRT Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.